Targeting Hepatocellular Carcinoma: What did we Discover so Far? - Wikidata - awgldk - TriplyDB

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

http://www.wikidata.org/entity/Q28077283

about

Extrahepatic metastasis of hepatocellular carcinoma to the paravertebral muscle: A case report.High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes.A proteomics-based investigation on the anticancer activity of alisertib, an Aurora kinase A inhibitor, in hepatocellular carcinoma Hep3B cells.miRNA-346 promotes proliferation, migration and invasion in liver cancer.Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: First evidence in preclinical hepatocellular carcinoma.Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway

P2860

Q40070928-8AFFF30C-D82D-4B8B-9E70-4B3A7D9707AD Q41413012-C3C413A3-4F17-406E-B9DB-23B6578C1832 Q41549246-49CB3287-6F0B-45AC-9AE0-118DBDDEFF86 Q41618935-B85129C4-8293-447F-8018-3E26C8D4A3C7 Q45872155-AFBC299E-8DC1-4299-8D03-241FA069EC4B Q58579029-5DE96653-BDCE-4966-B5F3-09C7D12EA0B0 Q58796653-03C1C734-8CF7-49E2-8908-D250E63B8A35

P2860

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

http://www.wikidata.org/entity/Q28077283

description

2016 nî lūn-bûn

@nan

2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

@ast

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

@en

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

@nl

type

label

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

@ast

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

@en

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

@nl

prefLabel

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

@ast

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

@en

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

@nl

P1433

Q28077283-E59E72B0-D228-47E3-B537-3D8404CEF62D

P1476

Q28077283-23691338-8A9C-4E7F-83C7-D10EF9313B1C

P2093

Q28077283-DF035FF0-E263-4DAF-B52B-72DF7AB87479

Q28077283-E468175F-C482-4D62-A073-EB74CA780303

P2860

Q28077283-07E81B43-7E11-4C00-AF68-65F02D9B8969

Q28077283-0AD6CF47-9ABF-4B49-A59E-7D8BD7DDC793

Q28077283-1423FB95-3BFD-4175-B239-C994FB99258E

Q28077283-193DE79D-B973-4CC7-B901-4AB7349B41DE

Q28077283-1AD36380-6F25-4070-8F81-529ECEF4A57D

Q28077283-1E117CA9-FCC0-4A64-BBC4-C7F36B109B3D

Q28077283-1E2AD648-1D7D-45E2-8E62-F3EB9DFB306C

Q28077283-24C2F194-0F18-4D08-9540-AEF24260A981

Q28077283-290BAE5E-7761-43F3-9EA1-1DDBB46012E4

Q28077283-2D3B0402-3DE2-40A6-AA45-C0AB4912BACF

P304

Q28077283-E2285FA2-F08C-4D44-806D-A62D1E296F5B

P31

Q28077283-5B848BEF-32E8-4D9C-8611-E8F214B083D6

P356

Q28077283-F192C706-5E4C-4434-897C-FD4DF6B55179

P407

Q28077283-136D0984-E0AC-44F4-8051-3B37539E7022

P433

Q28077283-A318F3F2-1A1F-4C98-BF90-028D3325F747

P478

Q28077283-F6BD7D7E-5454-4A63-984A-EFA0AB74F3FC

P50

Q28077283-C1646344-4D93-4FA2-AFDF-2FD6A4CC7E4E

Q28077283-C737F6CA-71FD-4A58-ACA6-4BFA15D73A90

P577

Q28077283-AA96C740-6A13-480D-A362-B075FEB3317B

P698

Q28077283-FBF252CC-D121-4033-AAFF-38DC314B4AAE

P932

Q28077283-19779810-2419-4A1E-9663-AAF63B534FC5

P356

P1433

Oncology reviews

P1476

Targeting Hepatocellular Carcinoma: What did we Discover so Far?

@en

P2093

Ana Filipa Brito

http://www.w3.org/2001/XMLSchema#string

José Guilherme Tralhão

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89

Liver-Directed Radiotherapy for Hepatocellular Carcinoma

New advances in hepatocellular carcinoma

Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region

Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma

Systemic therapies for hepatocellular carcinoma

Targeting the insulin-like growth factor pathway in hepatocellular carcinoma

Hepatocellular carcinoma: epidemiology, biology, diagnosis, and therapies

Management of hepatocellular carcinoma: An update

P304

302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4081/ONCOL.2016.302

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Ana Margarida Abrantes

Maria Filomena Botelho

P577

2016-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27994769

http://www.w3.org/2001/XMLSchema#string

P932

5136756

http://www.w3.org/2001/XMLSchema#string